Conclusion
The results of this study showed a slow but steady substitution of SGAs for FGAs over time, even in the same patients. However, monotherapy of SGA has remained low, albeit with a slight upward trend. The rates of concomitant use of anticholinergics decreased, but those of antidepressants, and anxiolytics/sleep medications, and mood stabilizers were unchanged.